About Roche Venture fund:
Roche, a venture capital founded in 2002, is known for being a global leader in the field of medicines and in-vitro diagnostics.
Roche has allocated CHF 500 million with the aim of investing in and developing commercially successful and innovative life science companies that benefit patients.
Offer:
Roche provides more than just funds, they are committed to providing:
- Expertise
- Long term vision
- Culture of innovation
Ideally, Roche would invest CHF 3-10 million for a first financing round with a 15% ownership stake but the amount always varies depending on the size of the company.
Investment phase:
Roche Venture Fund focuses on Series A investments.
Note: For therapeutics, they like to invest in preclinical companies, while for diagnostics, they prefer 12-18 months to launch.
Operating area:
Roche Venture Fund is operating in Basel, Switzerland, and South San Francisco, USA.
Business investment categories:
Roche Venture Fund invests in:
- Life science companies
- Pharmaceuticals companies
- Innovative medicines diagnostics and technologies companies
Portfolio:
Names of some companies that Roche Venture Fund invested in:
- Good Therapeutic: “Designing better protein drugs”
- Corvus Pharmaceutical: “Bringing ingenuity to drug development”
- Aligos Therapeutic: ” Our mission is to become a world leader in the development of targeted antiviral therapies”
You can find the full portfolio of Roche Venture Fund, here.
Get in touch with Roche Venture Fund:
If you are interested in collaborating, want to introduce an interesting technology, or if you have a potential idea of any of their main areas of interest, you can get in touch with Roche Venture Fund by filling one of these forms.
| References |
|---|
| 1. Roche Venture Fund, accessed November 2020, https://www.roche.com/ |
Leave A Comment?